Heron Therapeutics Inc vs Invesco WilderHill Clean Energy ETF — how do they compare? Heron Therapeutics Inc trades at $0.46 (market cap $91.46M), while Invesco WilderHill Clean Energy ETF trades at $34.25. The key difference: Invesco WilderHill Clean Energy ETF is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| HRTX | PBW | |
|---|---|---|
Market Cap | $91.46M | — |
Sector | Health | Sector/Thematic |
52-Week High | $1.96 | $46.99 |
52-Week Low | $0.39 | $22.23 |
Enterprise Value | $189.36M | — |
Signals from Pluang's Aura AI — not financial advice
HRTX trades at $0.4804, up 2.06% today, with a bullish technical signal despite mixed earnings. The stock shows a low price-to-sales ratio of 0.51 but negative profitability, with a net income margin of -20.53% in 2026. Recent Q1 2026 earnings missed expectations, though management reaffirmed full-year guidance. Analyst consensus is strongly bullish with 94.7% buy ratings.
Outlook remains speculative given persistent losses and cash burn, but potential upside exists if operational improvements materialize. Key risks include patent litigation outcomes and reliance on revenue growth to achieve profitability. Investors should weigh high analyst optimism against fundamental challenges.
PBW trades at $33.21, down 0.54% today, with a bearish technical signal from moving averages and oscillators showing neutral momentum. The ETF faces volatility tied to interest rate cycles, with recent news highlighting clean energy sector tailwinds from energy security concerns and data center demand. Key financial ratios are unavailable, limiting fundamental assessment.
Outlook hinges on clean energy policy support and interest rate sensitivity, with risks including sector volatility and competitive ETF performance. The bearish technical stance and rate-driven sell-offs underscore caution, though long-term energy transition trends offer potential upside.
Trailing returns across standard periods
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →PBW is an equal-weighted ETF that invests in U.S. companies leading the clean energy transition. It focuses on renewable energy, power conservation, and sustainable technologies like solar, wind, and energy storage.
Read more on PBW →